Back to AMERIPRISE FINANCIAL INC AMERIPRISE FINANCIAL INC

CORTCORT

Showing 8 of 30 quarters

Position history for AMERIPRISE FINANCIAL INCAMERIPRISE FINANCIAL INC's holdings in CORCEPT THERAPEUTICS INC

Yes. Ameriprise Financial holds 212,162 shares of CORT (Corcept Therapeutics), worth $18.4M, as of its Q2 2026 13F filing. It increased the position by 88 shares from Q1 2026. Ameriprise Financial has held CORT in every 13F on record since Q1 2019, 30 quarterly filings.

Current Value

$18.4M

Current Shares

212,162

Total Value Change

+$293,093

Total Shares Change

-180,111

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
212,162
+0.0%
$18.4M0.0%$86.95
28
2026-Q1
Decreased
212,074
-48.4%
$8.5M0.0%$40.31
0
2025-Q4
Increased
411,170
+84.9%
$14.3M0.0%$34.80
44
2025-Q3
Decreased
222,376
-47.0%
$18.5M0.0%$83.11
0
2025-Q2
Increased
419,183
+58.4%
$30.8M0.0%$73.40
41
2025-Q1
Decreased
264,581
-16.6%
$34.8M0.0%$114.22
0
2024-Q4
Decreased
317,318
-19.1%
$16M0.0%$50.39
0
2024-Q3
Increased
392,273
+11.1%
$18.2M0.0%$46.28
31

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used